The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Ben J.L. Van den Branden
Showing 1-8 of 8 articles
Impact of mitral valve treatment choice on mortality according to aetiology
Kortlandt F,
Velu J,
Schurer R,
Van den Branden B,
Bouma B,
Kelder J,
Eefting F,
Swaans MJ,
Rensing BJ,
Baan Jr J,
Van Der Heyden JA
April 16, 2019 | 10.4244/EIJ-D-18-00874
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Teeuwen K,
Van den Branden B,
Koolen J,
van der Schaaf R,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing BJ,
Suttorp MJ
March 20, 2015 | 10.4244/EIJY14M08_07
Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Van den Branden B,
Teeuwen K,
Koolen J,
van der Schaaf R,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing BJ,
Suttorp MJ
November 29, 2013 | 10.4244/EIJV9I7A138
Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II)
Teeuwen K,
Van den Branden B,
Rahel B,
Laarman G,
Thijssen J,
Kelder J,
Slagboom T,
ten Berg JM,
Suttorp MJ
June 28, 2013 | 10.4244/EIJV9I2A36
Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)
Van den Branden B,
Rahel B,
Laarman G,
Slagboom T,
Kelder J,
ten Berg JM,
Suttorp MJ
February 21, 2012 | 10.4244/EIJV7I10A190
The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety
Van den Branden B,
Luermans J,
Post M,
Plokker H,
ten Berg JM,
Suttorp MJ
September 30, 2010
Re-examining minimal luminal diameter relocation and quantitative coronary angiography - intravascular ultrasound correlations in stented saphenous vein grafts: methodological insights from the randomised RRISC trial
Semeraro O,
Agostoni P,
Verheye S,
van Langenhove G,
Van den Heuvel P,
Convens C,
Van den Branden B,
Bruining N,
Vermeersch P
March 20, 2009
One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with <i>de novo</i> native coronary artery lesions: the SPIRIT II study
Ruygrok P,
Desaga M,
Van den Branden B,
Rasmussen K,
Suryapranata H,
Dorange C,
Veldhof S,
Serruys P
November 20, 2007
1
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023